Insider Transactions in Q3 2024 at Recursion Pharmaceuticals, Inc. (RXRX)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 26
2024
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
6,000
-1.14%
|
$42,000
$7.0 P/Share
|
|
Sep 26
2024
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+1.13%
|
$6,000
$1.06 P/Share
|
|
Sep 17
2024
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
11,447
-0.16%
|
$68,682
$6.84 P/Share
|
|
Sep 11
2024
|
Michael Secora Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-1.06%
|
$90,000
$6.32 P/Share
|
|
Sep 11
2024
|
Michael Secora Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
39,375
+2.7%
|
$78,750
$2.22 P/Share
|
|
Sep 10
2024
|
Michael Secora Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-1.08%
|
$90,000
$6.17 P/Share
|
|
Sep 10
2024
|
Michael Secora Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
39,375
+2.75%
|
$78,750
$2.22 P/Share
|
|
Sep 05
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-2.56%
|
$120,000
$6.14 P/Share
|
|
Sep 05
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
20,000
+2.49%
|
-
|
|
Sep 04
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-2.56%
|
$120,000
$6.04 P/Share
|
|
Sep 04
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
20,000
+2.49%
|
-
|
|
Sep 03
2024
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
11,447
-0.16%
|
$68,682
$6.27 P/Share
|
|
Aug 30
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+0.65%
|
$10,000
$2.48 P/Share
|
|
Aug 29
2024
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
6,000
-1.14%
|
$42,000
$7.56 P/Share
|
|
Aug 29
2024
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+1.13%
|
$6,000
$1.06 P/Share
|
|
Aug 29
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+0.66%
|
$10,000
$2.48 P/Share
|
|
Aug 28
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+0.66%
|
$10,000
$2.48 P/Share
|
|
Aug 27
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+0.66%
|
$10,000
$2.48 P/Share
|
|
Aug 26
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+0.67%
|
$10,000
$2.48 P/Share
|
|
Aug 23
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+0.67%
|
$10,000
$2.48 P/Share
|
|
Aug 20
2024
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
11,447
-0.16%
|
$80,129
$7.12 P/Share
|
|
Aug 15
2024
|
David J Mauro Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,146
-5.8%
|
$84,876
$6.69 P/Share
|
|
Aug 15
2024
|
Tina Marriott Larson President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,319
-2.67%
|
$85,914
$6.69 P/Share
|
|
Aug 15
2024
|
Michael Secora Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,962
-0.88%
|
$71,772
$6.69 P/Share
|
|
Aug 15
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
26,082
-3.44%
|
$156,492
$6.69 P/Share
|
|
Aug 14
2024
|
Michael Secora Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-1.09%
|
$90,000
$6.35 P/Share
|
|
Aug 14
2024
|
Michael Secora Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
39,375
+2.77%
|
$78,750
$2.22 P/Share
|
|
Aug 13
2024
|
Michael Secora Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-1.11%
|
$90,000
$6.35 P/Share
|
|
Aug 13
2024
|
Michael Secora Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
39,375
+2.82%
|
$78,750
$2.22 P/Share
|
|
Aug 08
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-2.57%
|
$120,000
$6.5 P/Share
|
|
Aug 08
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
20,000
+2.5%
|
-
|
|
Aug 07
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
30,000
-3.8%
|
$210,000
$7.1 P/Share
|
|
Aug 07
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
30,000
+3.66%
|
-
|
|
Aug 06
2024
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
11,447
-0.16%
|
$68,682
$6.82 P/Share
|
|
Aug 01
2024
|
Najat Khan Chief R&D Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
496,972
+50.0%
|
-
|
|
Jul 25
2024
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
6,000
-1.11%
|
$48,000
$8.13 P/Share
|
|
Jul 25
2024
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+1.1%
|
$6,000
$1.06 P/Share
|
|
Jul 23
2024
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
11,447
-0.16%
|
$91,576
$8.48 P/Share
|
|
Jul 11
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-6.18%
|
$350,000
$7.47 P/Share
|
|
Jul 11
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
50,000
+5.82%
|
-
|
|
Jul 10
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-6.18%
|
$350,000
$7.48 P/Share
|
|
Jul 10
2024
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
50,000
+5.82%
|
-
|
|
Jul 10
2024
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
25,000
-3.19%
|
-
|
|
Jul 10
2024
|
Michael Secora Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-1.13%
|
$105,000
$7.24 P/Share
|
|
Jul 10
2024
|
Michael Secora Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
39,375
+2.87%
|
$78,750
$2.22 P/Share
|
|
Jul 09
2024
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
11,447
-0.16%
|
$80,129
$7.32 P/Share
|
|
Jul 09
2024
|
Michael Secora Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-1.15%
|
$105,000
$7.32 P/Share
|
|
Jul 09
2024
|
Michael Secora Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
39,375
+2.92%
|
$78,750
$2.22 P/Share
|
|
Jul 01
2024
|
Blake Borgeson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,441
+0.02%
|
-
|
|
Jul 01
2024
|
Terry Ann Burrell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,843
+2.52%
|
-
|